- Report
- April 2018
- 80 Pages
Global
From €3170EUR$3,300USD£2,729GBP
- Report
- March 2021
- 45 Pages
Global
From €2396EUR$2,495USD£2,063GBP
- Report
- February 2020
- 137 Pages
Global
From €7679EUR$7,995USD£6,611GBP
- Report
- May 2021
- 94 Pages
Global
€21130EUR$22,000USD£18,192GBP
- Report
- October 2018
- 71 Pages
Global
From €6147EUR$6,400USD£5,292GBP
- Report
- September 2018
- 162 Pages
Global
From €5763EUR$6,000USD£4,961GBP
- Report
- August 2018
- 24 Pages
Global
From €2401EUR$2,500USD£2,067GBP
- Report
- March 2023
- 36 Pages
Global
From €1873EUR$1,950USD£1,612GBP
- Report
- December 2021
- 57 Pages
Global
From €1873EUR$1,950USD£1,612GBP
- Report
- November 2023
- 90 Pages
Global
From €3500EUR$3,904USD£3,119GBP
- Book
- April 2020
- 336 Pages
- Book
- April 2018
- 224 Pages
- Book
- June 2015
- 392 Pages
- Book
- July 2014
- 224 Pages
Rheumatoid Arthritis (RA) is a chronic autoimmune disorder that affects the joints and other organs. It is a type of inflammatory arthritis that is caused by an overactive immune system. RA is a major cause of disability and is the most common form of inflammatory arthritis. It affects people of all ages, but is more common in women than men. Symptoms of RA include joint pain, swelling, stiffness, and decreased range of motion. Treatment for RA includes medications, physical therapy, and lifestyle changes.
The RA market within the context of Allergy and Immunology is a rapidly growing market. It is driven by the increasing prevalence of RA, the development of new treatments, and the increasing demand for better treatments. The market is expected to grow due to the increasing awareness of RA and the increasing demand for better treatments.
Some companies in the RA market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Novartis, Pfizer, and Roche. Show Less Read more